- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate in United Kingdom
Total 3794 results
-
University of NottinghamActive, not recruitingColorectal Cancer | Prostate CancerUnited Kingdom
-
Aragon Pharmaceuticals, Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom, Moldova, Republic of
-
Belfast Health and Social Care TrustActive, not recruiting
-
Mid and South Essex NHS Foundation TrustCompletedProstate CancerUnited Kingdom
-
St. Luke's Hospital, IrelandUnknownProstate CancerIreland, United Kingdom
-
Imperial College LondonWithdrawn
-
Sophiris Bio CorpCompletedProstate CancerUnited Kingdom, United States
-
Weill Medical College of Cornell UniversityProgenics Pharmaceuticals, Inc.; Viewray Inc.RecruitingProstate CancerUnited States, United Kingdom
-
Hull University Teaching Hospitals NHS TrustUniversity of HullCompleted
-
Advanced Medical Diagnostics s.a.CompletedProstate CancerGermany, United Kingdom, Belgium, Czech Republic, Hungary
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomRecruiting
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
BayerCompletedNeoplasm Metastasis | Prostate CancerSweden, United Kingdom
-
University of SurreyRoyal Surrey County Hospital NHS Foundation TrustNot yet recruitingProstate CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomRecruitingProstate CancerUnited Kingdom
-
Asana BioSciencesTerminatedProstate Cancer | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Prostate Neoplasms, Castration-resistantUnited States
-
Cougar Biotechnology, Inc.CompletedProstatic Neoplasms | Prostate CancerUnited States, United Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Cambridge; Janssen-Cilag Ltd.Recruiting
-
Royal Marsden NHS Foundation TrustJanssen, LPRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)United Kingdom
-
Wirral University Teaching Hospital NHS TrustNovartisCompleted
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom
-
University College, LondonUniversity College London Hospitals; Sheffield Teaching Hospitals NHS Foundation... and other collaboratorsActive, not recruiting
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
Swedish Medical CenterRecruitingProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Institute of Cancer Research, United KingdomCancer Research UK; National Institute for Health Research, United KingdomRecruitingProstate Cancer | BRCA1 Mutation | BRCA2 MutationUnited Kingdom
-
GlaxoSmithKlineCompletedNeoplasmsUnited States, United Kingdom
-
Wirral University Teaching Hospital NHS TrustCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Oncternal Therapeutics, IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Institutes of Health (NIH)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterPatient-Centered Outcomes Research InstituteCompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateUnited States
-
University of California, San FranciscoApproved for marketingProstate Cancer | Prostate Adenocarcinoma | ProstateUnited States
-
University of UtahTerminatedStage IV Prostate Cancer | Metastatic Prostatic Adenocarcinoma | Castration-Sensitive Prostate Carcinoma | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
Imperial College LondonCompleted
-
BayerCompletedNeoplasm Metastasis | Prostate CancerUnited Kingdom
-
Crozer-Keystone Health SystemRecruitingProstate Cancer | Prostate Adenocarcinoma | Prostate NeoplasmUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedProstate Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
NHS LothianRecruitingProstate Cancer | DNA Damage | Volatile Organic Compounds | Radiotherapy Side EffectsUnited Kingdom
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
Hoffmann-La RocheTerminatedProstate CancerSpain, United Kingdom, France, Germany, Italy, Netherlands
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States